Daniel Klamer

Pridopidine: Overview of Pharmacology and Rationale for its Use in Huntington's

Disease

Susanna Waters, J. Tedroff, Henrik Ponten, Daniel Klamer, C. Sonesson, N. Waters
Journal of Huntingtons Disease - 2018

Increased brain nitric oxide levels following ethanol

administration

N. Finnerty, S. L. O'Riordan, Daniel Klamer, J. Lowry, Erik Pålsson
Nitric oxide - 2015

Co-administration of the dopaminergic stabilizer pridopidine and tetrabenazine in

rats

Susanna Waters, Henrik Ponten, Daniel Klamer, N. Waters
Journal of Huntington's Disease - 2014

The dopaminergic stabilizers pridopidine and ordopidine enhance cortico-striatal Arc gene

expression

Susanna Waters, Henrik Ponten, Malin Edling, B. Svanberg, Daniel Klamer, N. Waters
Journal of Neural Transmission - 2014

The genetic contribution of the NO system at the glutamatergic post-synapse to schizophrenia: Further evidence and

meta-analysis

H. Weber, Daniel Klamer, F. Freudenberg, S. Kittel-Schneider, O. Rivero, C. J. Scholz, J. Volkert, J. Kopf, J. Heupel, S. Herterich, R. Adolfsson, A. Alttoa, A. Post, H. Grussendorf, A. Kramer, A. Gessner, B. Schmidt, S. Hempel, C. P. Jacob, J. Sanjuan, M. D. Molto, K. P. Lesch, C. M. Freitag, L. Kent, A. Reif
European Neuropsychopharmacology - 2014

L-lysine as adjunctive treatment in patients with schizophrenia: a single-blinded, randomized, cross-over pilot

study.

Caroline Wass, Daniel Klamer, Evangelos Katsarogiannis, Erik Pålsson, Lennart Svensson, Kim Fejgin, Inga-Britt Bogren, Jörgen Engel, Birgitta Rembeck
BMC medicine - 2011

Prefrontal NMDA receptor antagonism reduces impairments in pre-attentive information

processing.

Daniel Klamer, Lennart Svensson, Kim Fejgin, Erik Pålsson
European Neuropsychopharmacology - 2011

Information processing deficits and nitric oxide signalling in the phencyclidine model of

schizophrenia.

Erik Pålsson, John Lowry, Daniel Klamer
Psychopharmacology - 2010

Noise benefit in prepulse inhibition of the acoustic startle

reflex.

Erik Pålsson, Göran Söderlund, Daniel Klamer, Filip Bergquist
Psychopharmacology - 2010

Increased cortical nitric oxide release after phencyclidine

administration.

Erik Pålsson, Niall Finnerty, Kim Fejgin, Daniel Klamer, Caroline Wass, Lennart Svensson, John Lowry
Synapse (New York, N.Y.) - 2009

Prefrontal GABA(B) Receptor Activation Attenuates Phencyclidine-Induced Impairments of Prepulse Inhibition: Involvement of Nitric

Oxide.

Kim Fejgin, Erik Pålsson, Caroline Wass, Niall Finnerty, John Lowry, Daniel Klamer
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology - 2009

The importance of nitric oxide in social

dysfunction.

Caroline Wass, Daniel Klamer, Kim Fejgin, Erik Pålsson
Behavioural brain research - 2009

Systemic adminstration of Phencyclidine increases Nitric oxide levels in the rat medial prefrontal

cortex

Daniel Klamer, Kim Fejgin, Erik Pålsson, Niall J Finnerty, Caroline Wass, Jörgen Engel, Lennart Svensson, John P Lowry
Presented at EWCBR. March, 2008, Les Arcs, France - 2008

Ethanol increases brain nitric oxide levels in

rats

Erik Pålsson, Niall Finnerty, Kim Fejgin, Finbar Brown, Daniel Klamer, Lennart Svensson, John P Lowry
Presented at EWCBR. March, 2008, Les Arcs, France - 2008

Cognitive dysfunctions in schizophrenia: focus on the nitric oxide pathway in rodent

models

Daniel Klamer, Kim Fejgin, Caroline Wass, Niall J Finnerty, John P Lowry, Jörgen Engel, Lennart Svensson, Erik Pålsson
Presented at Cognitive Dysfunctions in Disease: Mechanisms and Therapies. Stockholm, Sweden. April 2008 - 2008

Nitric oxide and GABAB-sensitive mechanisms in the prefrontal cortex are important for the disruptive effects of phencyclidine on prepulse

inhibition

Kim Fejgin, Erik Pålsson, Caroline Wass, Jörgen Engel, Lennart Svensson, Daniel Klamer
Presented at Cognitive Dysfunctions in Disease: Mechanisms and Therapies. April 2008, Stockholm, Sweden, - 2008

Nitric oxide synthase inhibition attenuates phencyclidine-induced disruption of cognitive

flexibility.

Caroline Wass, Lennart Svensson, Kim Fejgin, Erik Pålsson, Trevor Archer, Jörgen Engel, Daniel Klamer
Pharmacology, biochemistry, and behavior - 2008

Nitric oxide signaling in the medial prefrontal cortex is involved in the biochemical and behavioral effects of

phencyclidine.

Kim Fejgin, Erik Pålsson, Caroline Wass, Lennart Svensson, Daniel Klamer
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology - 2008

Contributions of dopamine D1, D2, and D3 receptor subtypes to the disruptive effects of cocaine on prepulse inhibition in

mice.

James M Doherty, Virginia L Masten, Susan B Powell, Rebecca J Ralph, Daniel Klamer, Malcolm J Low, Mark A Geyer
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology - 2008

Agmatine attenuates the disruptive effects of phencyclidine on prepulse

inhibition.

Erik Pålsson, Kim Fejgin, Caroline Wass, Daniel Klamer
European journal of pharmacology - 2008

The atypical antipsychotic, aripiprazole, blocks phencyclidine-induced disruption of prepulse inhibition in

mice.

Kim Fejgin, Sergej Safonov, Erik Pålsson, Caroline Wass, Jörgen Engel, Lennart Svensson, Daniel Klamer
Psychopharmacology - 2007

The amino acid L-lysine blocks the disruptive effect of phencyclidine on prepulse inhibition in

mice.

Erik Pålsson, Kim Fejgin, Caroline Wass, Jörgen Engel, Lennart Svensson, Daniel Klamer
Psychopharmacology - 2007

Effects of phencyclidine on spatial learning and memory: nitric oxide-dependent

mechanisms

Caroline Wass, Trevor Archer, Erik Pålsson, Kim Fejgin, Daniel Klamer, Jörgen Engel, Lennart Svensson
Behav Brain Res - 2006

Phencyclidine affects memory in a nitric oxide-dependent manner: working and reference

memory

Caroline Wass, Trevor Archer, Erik Pålsson, Kim Fejgin, A. Alexandersson, Daniel Klamer, Jörgen Engel, Lennart Svensson
Behav Brain Res - 2006

Effects of phencyclidine on acoustic startle and prepulse inhibition in neuronal nitric oxide synthase deficient

mice

Daniel Klamer, Jörgen Engel, Lennart Svensson
Eur Neuropsychopharmacol - 2005

Antagonism of the nitric oxide synthase inhibitor, L-NAME, of the effects of phencyclidine on latent inhibition in taste aversion

conditioning

Daniel Klamer, Erik Pålsson, Caroline Wass, Trevor Archer, Jörgen Engel, Lennart Svensson
Behav Brain Res - 2005

The effects of phencyclidine on latent inhibition in taste aversion conditioning: differential effects of preexposure and

conditioning

Erik Pålsson, Daniel Klamer, Caroline Wass, Trevor Archer, Jörgen Engel, Lennart Svensson
Behav Brain Res - 2005

Activation of a nitric-oxide-sensitive cAMP pathway with phencyclidine: elevated hippocampal cAMP levels are temporally associated with deficits in prepulse

inhibition

Daniel Klamer, Erik Pålsson, Kim Fejgin, J. Zhang, Jörgen Engel, Lennart Svensson
Psychopharmacology (Berl) - 2005

Selective interaction of nitric oxide synthase inhibition with phencyclidine: behavioural and NMDA receptor binding studies in the

rat

Daniel Klamer, J. Zhang, Jörgen Engel, Lennart Svensson
Behav Brain Res - 2005

Schizofrena patienter saknar förmågan att filtrera sensorisk

information

Daniel Klamer
Medikament 2005 - 2005

Phencyclidine-induced behaviour in mice prevented by methylene

blue

Daniel Klamer, Jörgen Engel, Lennart Svensson
Basic & Clinical Pharmacology & Toxicology - 2004

Habituation of acoustic startle is disrupted by psychotomimetic drugs: differential dependence on dopaminergic and nitric oxide modulatory

mechanisms

Daniel Klamer, Erik Pålsson, Aron Revesz, Jörgen Engel, Lennart Svensson
Psychopharmacology (Berl) - 2004

The neuronal selective nitric oxide synthase inhibitor, Nomega-propyl-L-arginine, blocks the effects of phencyclidine on prepulse inhibition and locomotor activity in

mice

Daniel Klamer, Jörgen Engel, Lennart Svensson
Eur J Pharmacol - 2004

Schizophrenia and Nitric Oxide: Deficits in Information Processing Invetigated in Animal

Models

Daniel Klamer
2004

Daniel Klamer

Gästforskare

Publikationer